← Front pageReports · Trackers
DRASKER

VACCINE SAFETY & INJURY CLAIMS TRACKER

CASES, NOT VERDICTS ON SAFETY

Litigation

Lawsuits over COVID-19 vaccine safety, efficacy and trial-conduct claims, court-ordered releases of safety data, and challenges to the injury-compensation framework. Allegations are labeled as allegations; procedural rulings (removal, remand, preemption, immunity, pace of disclosure) are labeled as procedural. Allegations in a complaint are not findings, and a procedural ruling says nothing about whether a vaccine is safe.

7Cases tracked
5Still active
8Dockets watched weekly
0Awaiting review after a docket change

Selection: a case is tracked when it is a government or relator action over vaccine safety, efficacy or trial-conduct representations; produced court-ordered release of safety data; or challenges the PREP Act / CICP framework. Individual injury suits and mandate or speech cases are not tracked unless they produce a published appellate ruling on one of those questions. A docket change flags a case for editor review; it never rewrites the case automatically.

Pending (1)

pendingGovernment or relator action over vaccine safety, efficacy or trial-conduct representations

Florida v. Pfizer Inc. and Albert Bourla (COVID-19 vaccine marketing)

Parties
Florida Office of the Attorney General, Department of Legal Affairs v. Pfizer Inc., Albert Bourla
Court / jurisdiction
Circuit Court of the Nineteenth Judicial Circuit in and for St. Lucie County, Florida (Civil Division)
Docket
Not shown on the filed complaint (e-filing no. 258276669)
Filed
Oct 1, 2026
Product / manufacturer
Pfizer-BioNTech COVID-19 vaccine (Comirnaty) — Pfizer
Type of claim
State consumer-protection enforcement (Florida Deceptive and Unfair Trade Practices Act)

Major allegations: The complaint alleges Pfizer and its chief executive deceived Florida consumers by assuring them the vaccine posed no material safety risks while Pfizer knew of data on myocarditis and pericarditis in minors, had reason to expect harms in early pregnancy, and held thousands of reports of other adverse events; and by telling consumers vaccination would stop transmission when the vaccine's effect on transmission had not been tested (complaint ¶¶ 7–8, 11–13). The state brings the action under sections 501.207(1)(a) and (1)(b), Florida Statutes.

These are the state's allegations. No court has ruled on them.

Timeline, motions and rulings

  1. Lawsuit allegation Complaint e-filed in St. Lucie County circuit court (filing no. 258276669). document
Primary documents, last checked and revision history

Status as of Oct 6, 2026 · last checked Nov 11, 2026 · revision 2

  1. Revision 1 — created, Oct 6, 2026
  2. Revision 2 — updated, Oct 6, 2026 (criterion, topics)

On appeal (3)

on appealGovernment or relator action over vaccine safety, efficacy or trial-conduct representations

Kansas v. Pfizer Inc. (COVID-19 vaccine marketing)

Parties
State of Kansas v. Pfizer Inc.
Court / jurisdiction
District Court of Thomas County, Kansas; removed to U.S. District Court for the District of Kansas (No. 6:24-cv-01128); appeal in the U.S. Court of Appeals for the Tenth Circuit (No. 25-3085)
Docket
D. Kan. 6:24-cv-01128; 10th Cir. 25-3085
Filed
Jun 17, 2024
Product / manufacturer
Pfizer-BioNTech COVID-19 vaccine (Comirnaty) — Pfizer
Type of claim
State consumer-protection enforcement (Kansas Consumer Protection Act)

Major allegations: Kansas alleges Pfizer misrepresented the vaccine's safety and effectiveness, including its safety in pregnancy and the risk of myocarditis, in violation of the Kansas Consumer Protection Act.

These are the state's allegations. The federal rulings so far concern which court hears the case, not whether the allegations are true.

Timeline, motions and rulings

  1. Lawsuit allegation Kansas files suit in Thomas County District Court (date as reported; the state-court filing is not online). news report
  2. Other public record Pfizer removes the case to federal court (D. Kan. No. 6:24-cv-01128). docket
  3. Court ruling The federal court grants Kansas's motion to send the case back to state court (a procedural ruling on jurisdiction). news report
  4. Other public record Tenth Circuit dockets Pfizer's appeal (No. 25-3085); Kansas is the appellee. docket
Primary documents, last checked and revision history

Status as of Oct 6, 2026 · last checked Nov 11, 2026 · revision 2

  1. Revision 1 — created, Oct 6, 2026
  2. Revision 2 — updated, Oct 6, 2026 (criterion, topics)
on appealGovernment or relator action over vaccine safety, efficacy or trial-conduct representations

Texas v. Pfizer Inc. (COVID-19 vaccine efficacy claims)

Parties
State of Texas v. Pfizer Inc.
Court / jurisdiction
Lubbock County district court; removed to U.S. District Court for the Northern District of Texas (No. 5:23-cv-00312); appeal in the U.S. Court of Appeals for the Fifth Circuit (No. 25-10182)
Docket
N.D. Tex. 5:23-cv-00312; 5th Cir. 25-10182
Filed
Nov 2023
Product / manufacturer
Pfizer-BioNTech COVID-19 vaccine (Comirnaty) — Pfizer
Type of claim
State consumer-protection enforcement (Texas Deceptive Trade Practices Act)

Major allegations: Texas alleges Pfizer misrepresented the vaccine's efficacy, including its advertised 95 percent efficacy figure, in violation of the Texas Deceptive Trade Practices Act. The federal district court dismissed the case; Texas appealed.

The dismissal rested on federal immunity and preemption grounds as reported, not on a finding about the vaccine's safety or efficacy. The appeal is undecided.

Timeline, motions and rulings

  1. Lawsuit allegation Texas files suit in Lubbock County district court (month as reported; the state-court filing is not online). news report
  2. Other public record Pfizer files a notice of removal to federal court (N.D. Tex. No. 5:23-cv-00312, docket entry 1). docket
  3. Court ruling The district court case is terminated after the court dismisses the complaint (reported grounds: PREP Act immunity and federal preemption). docket
  4. Other public record Fifth Circuit dockets Texas's appeal (No. 25-10182). docket
  5. Other public record Fifth Circuit hears oral argument. docket
Primary documents, last checked and revision history

Status as of Oct 6, 2026 · last checked Nov 11, 2026 · revision 2

  1. Revision 1 — created, Oct 6, 2026
  2. Revision 2 — updated, Oct 6, 2026 (criterion, topics)
on appealGovernment or relator action over vaccine safety, efficacy or trial-conduct representations

U.S. ex rel. Brook Jackson v. Ventavia Research Group and Pfizer (False Claims Act)

Parties
Brook Jackson (relator) v. Ventavia Research Group, Pfizer, ICON
Court / jurisdiction
U.S. District Court for the Eastern District of Texas; U.S. Court of Appeals for the Fifth Circuit
Docket
E.D. Tex. 1:21-cv-00008; 5th Cir. 24-40564
Filed
Jan 8, 2021
Product / manufacturer
Pfizer-BioNTech COVID-19 vaccine trial — Pfizer
Type of claim
False Claims Act (qui tam)

Major allegations: A former trial-site regional director alleges protocol violations at Ventavia sites in Pfizer's vaccine trial — including unblinding, inadequate adverse-event follow-up and data-integrity problems — and that the defendants made false claims to the government.

These are the relator's allegations. The district court dismissed the case and the appeal is pending; no court has found the alleged trial misconduct.

Timeline, motions and rulings

  1. Lawsuit allegation Qui tam complaint filed (later unsealed). docket
  2. Court ruling District court case terminated after dismissal. docket
  3. Other public record Fifth Circuit dockets the relator's appeal (No. 24-40564). docket
Primary documents, last checked and revision history

Status as of Oct 6, 2026 · last checked Nov 11, 2026 · revision 1

  1. Revision 1 — created, Oct 6, 2026